Core Insights - The 2025 Shandong Wealth Creation List highlights the strong performance of the tire industry, with a total wealth creation amounting to 2.5 trillion yuan, showcasing the industry's significant contribution to the local economy [6][13]. Group 1: Leading Companies and Wealth Rankings - Huachin Rubber, led by the Niu Zhishun family, ranks first in the tire industry with a wealth value of 55.128 billion yuan, placing it in the top ten of the overall list [6][8]. - Linglong Tire and Haomai Group form a strong second tier, with the Wang Xicheng family of Linglong Tire at 33.596 billion yuan (ranked 18th) and Zhang Gongyun of Haomai Group at 33.581 billion yuan (ranked 19th), indicating their close financial standings [3][10]. - Other notable entrants in the top 100 include Shang Jiyong of Wanda Holdings, Liu Shengjun and Liu Xia of Haomai Group, Yuan Zhongxue of Sailun and Soft Control, and Qin Long of Senqilin, further solidifying the wealth landscape of Shandong's tire industry [3][10]. Group 2: Industry Strength and Transformation - The tire industry is recognized as a pillar industry in Shandong, demonstrating its robust capabilities and the successful transition from traditional manufacturing to high-end, intelligent production [4][11]. - Continuous focus on core business operations has led to synchronized growth in personal wealth and corporate value among Shandong tire entrepreneurs, contributing to the region's reputation as a stronghold in the tire sector [6][13].

Core Viewpoint - The city of Liaocheng is transitioning towards high-quality development, focusing on the chemical new materials sector as a key driver for economic growth during the "14th Five-Year Plan" period, with GDP expected to exceed 330 billion yuan and industrial revenue approaching 500 billion yuan [1][3]. Group 1: Development Strategy - Liaocheng aims to redefine its chemical industry by shifting from traditional bulk production to high-end, refined products, particularly in the chemical new materials sector [3][4]. - The city is leveraging its local advantages to enhance its industrial chain, with leading companies like Luxi Chemical expanding into high-performance materials such as polycarbonate and nylon [5][6]. Group 2: Innovation and Collaboration - Liaocheng is fostering an innovation chain driven by market demand, with key enterprises like Luxi Chemical acting as "chain leaders" to spearhead collaborative research and development efforts [6][7]. - The city has established a robust ecosystem for innovation, hosting numerous manufacturing service events to ensure that research aligns closely with market needs [6][8]. Group 3: Sustainable Development - The transformation towards new quality productivity emphasizes green production, with Liaocheng's chemical new materials sector aligning with sustainability goals through smart management and eco-friendly practices [7][8]. - The city has successfully implemented smart management platforms in its chemical parks, enhancing operational efficiency and reducing environmental impact [12][14]. Group 4: Infrastructure and Investment - Liaocheng is focused on building high-energy chemical industrial parks and expanding existing ones to facilitate a more integrated industrial ecosystem [8][10]. - The city has attracted significant investments, including a notable 20.6 billion yuan project from Sinochem Group, highlighting the effectiveness of its targeted investment strategies [8][10]. Group 5: Digital Transformation - The digital transformation in Liaocheng's chemical sector is reshaping production and management processes, enhancing competitiveness through smart technologies [12][14]. - Companies are utilizing digital tools for precise control over production, energy efficiency, and improved market responsiveness, establishing a new competitive edge in the industry [12][15].

内容概要：预分散母胶粒，也叫预分散橡胶助剂、橡胶助剂母胶粒、母胶粒。是以聚合物（一般是 EPDM、SBR、NBR、EVA）为载体，加橡胶助剂和软化剂，通过特殊工艺将传统预分散橡胶助剂到聚 合物中，得到一定浓度的均匀预分散体（挤出造粒）。预分散橡胶助剂是传统橡胶助剂的升级换代品， 具有无粉尘、易分散、适合自动称量和自动连续低温混炼、提高混炼效率、储存稳定好等优点，日益受 到业内重视，已在橡胶制品中大量应用。我国对橡胶助剂母粒的最早工业化应用是在20世纪90年代初， 直到2017年11月，关于预分散橡胶助剂的标准才由中国橡胶工业协会发布团体标准《预分散橡胶助剂通 用规范》（T/CRIA25001—2017），预分散橡胶助剂行业逐步规范。根据中橡协橡胶助剂专委会对协会 下企业的统计，国内预分散母胶粒产量从2019年的6.2万吨增长至2024年的8.68万吨，年复合增长率达 12.2%。2024年，受汽车、橡胶、轮胎等工业的快速发展影响，预分散母胶粒产量增速达14.7%。受到 主要原材料价格下降影响，2022-2024年，中国预分散母胶粒售价呈下滑态势，以艾克姆为例，2024年 期预分散母胶粒产品售价为2.53万元/ ...

Group 1: Company Announcements - Zhongwei Company plans to acquire 64.69% equity of Hangzhou Zhonggui through a combination of share issuance and cash payment, aiming to enhance its capabilities in CMP equipment and solutions [1] - Lixun Precision intends to repurchase shares worth between 1 billion to 2 billion RMB for employee stock ownership plans or equity incentives, with a maximum repurchase price of 86.96 RMB per share [2] - ZaiJing Pharmaceutical has reached a global strategic cooperation and licensing agreement with AbbVie for the development and commercialization of ZG006, receiving an upfront payment of 100 million USD [3] - Tianci Materials expects a net profit increase of 127% to 231% for 2025, driven by significant growth in lithium-ion battery material sales [4] - Meike Home plans to acquire 100% equity of Shenzhen Wande Technology through share issuance and cash payment, with stock resuming trading on January 5, 2026 [6][7] - ST KeliDa is planning a change in control, with stock suspension starting January 5, 2026, due to the transfer of 100% equity of its controlling shareholder [8] - Xinzhou Bang intends to invest approximately 260 million USD in a lithium-ion battery materials project in Saudi Arabia, enhancing its global capacity and supply chain [9] Group 2: Financial Performance - Kid's King anticipates a net profit increase of 51.72% to 82.06% for 2025 [9] - Guangku Technology expects a net profit growth of 152% to 172% for 2025 [9] Group 3: Mergers and Acquisitions - Xidi Micro plans to acquire 100% equity of Chengxin Micro for 310 million RMB [9] - Haili Biological's subsidiary intends to acquire 51% equity of seven dental chain companies for 61.2 million RMB [9]

Group 1: Mergers and Acquisitions - Haili Biological's subsidiary, Ruisheng Biological, plans to invest 61.2 million yuan to acquire 51% equity in seven dental chain companies located in Yangzhou and Changzhou, which is expected to increase the company's revenue by approximately 100 million yuan and net profit by over 7 million yuan [1] - Yanggu Huatai has decided to terminate the issuance of shares and cash payment to acquire 99.64% equity in Bomi Technology, opting to negotiate for partial equity acquisition in cash instead [2] - Yachuang Electronics intends to issue shares and pay cash totaling 317 million yuan to purchase 40% equity in Shenzhen Ouchuang Semiconductor and 45% equity in Shenzhen Yihai Nengda, constituting a major asset restructuring [3] Group 2: Earnings Forecasts - Guangku Technology anticipates a net profit attributable to shareholders of 169 million to 182 million yuan for 2025, representing a year-on-year growth of 152% to 172% [4] Group 3: Shareholding Changes - Jianzhijia's actual controller, Yunnan Xiangqun, plans to increase its stake in the company by up to 2% through a concentrated bidding process, with an investment amount of 50 million yuan sourced from its own funds and a loan of up to 45 million yuan from CITIC Bank [5] - Zhenzhong Investment, a significant shareholder of Lvdiaofeng, plans to reduce its stake by no more than 1% through a concentrated bidding process, equating to a maximum of 680,000 shares [6] - Two shareholders of Lingzhi Software plan to reduce their holdings by a combined total of up to 1.43%, with one shareholder reducing by up to 3.281 million shares (0.82% of total shares) and the other by up to 2.4492 million shares (0.61% of total shares) [7] Group 4: Tax Issues - Tianyue Advanced announced that it needs to pay a total of 82.9728 million yuan in corporate income tax and late fees, which will be recorded in the 2025 financial results, expected to reduce the company's net profit for that year [8] - China Pharmaceutical's wholly-owned subsidiary, Hainan Tongyong Sanyang Pharmaceutical and Hainan Kangli Pharmaceutical, received tax notices requiring a total payment of approximately 65.2178 million yuan in taxes and late fees, which will also impact the company's net profit for 2025 [9][10] Group 5: Regulatory Issues - Platelite has received a notice from the China Securities Regulatory Commission regarding a case of suspected illegal information disclosure, leading to an official investigation [11] Group 6: Legal Matters - Baotailong announced that its subsidiary, Shuangyashan Longmei Tiantai Coal Chemical Co., is involved in a significant lawsuit that has entered the second instance, with a ruling requiring it to pay 316 million yuan in contract price and interest, while also receiving compensation and a return of a quality guarantee deposit [12]

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2026-001 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 山东阳谷华泰化工股份有限公司 第六届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 山东阳谷华泰化工股份有限公司（以下简称"公司"）第六届董事会第十八 次会议（紧急）通知已于2025年12月31日以通讯方式送达全体董事，本次会议于 2025年12月31日在公司三楼会议室以现场与通讯表决相结合的方式召开，董事长 王文博于本次董事会会议上就紧急通知的原因作出了说明。应参加会议董事7名， 亲自出席董事7名，其中独立董事3名，董事王文一、朱德胜、张洪民以通讯表决 的方式出席会议。会议由公司董事长王文博先生主持，公司高级管理人员列席了 会议，符合《中华人民共和国公司法》和《公司章程》的规定。 （一）审议通过《关于终止发行股份及支付现金购买资产并募集配套资金 暨关联交易事项并撤回申请文件的议案》 鉴于当前市场环境变化，为切实维护公司及广 ...

经核查，我们认为：终止本次交易的事项是基于当前市场环境及公司资本运 作规划做出的合理决策，有利于更好地保障公司及广大投资者利益，是在各方平 等协商的基础上，遵循公平、公正、公开的原则进行，不存在损害公司及股东利 益，尤其是中小股东利益的情形，不会影响公司的独立性，亦不会对公司持续经 营能力产生不利影响。综上所述，我们一致同意将该议案提交公司董事会审议。 表决结果：同意3票，反对0票，弃权0票。 本议案尚需提交公司董事会审议。 山东阳谷华泰化工股份有限公司 第六届董事会独立董事专门会议第八次会议决议 山东阳谷华泰化工股份有限公司（以下简称"公司"）第六届董事会独立董 事专门会议第八次会议于2025年12月31日以通讯方式召开。本次会议由独立董事 专门会议召集人朱德胜先生召集主持，应到独立董事三人，实到独立董事三人， 符合《公司法》《上市公司独立董事管理办法》以及相关法律法规的有关规定。 本次会议讨论并通过如下议案： 一、审议通过《关于终止发行股份及支付现金购买资产并募集配套资金暨 关联交易事项并撤回申请文件的议案》 独立董事：朱德胜、张洪民、刘克健 二〇二六年一月一日 ...

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2026-002 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 山东阳谷华泰化工股份有限公司（以下简称"公司"）于2025年12月31日召 开第六届董事会第十八次会议，审议通过了《关于终止发行股份及支付现金购买 资产并募集配套资金暨关联交易事项并撤回申请文件的议案》，同意公司终止本 次发行股份及支付现金购买资产并募集配套资金事项。现将相关情况公告如下： 一、本次交易的基本情况 公司拟以发行股份及支付现金的方式向海南聚芯科技合伙企业（有限合伙）、 王传华、武凤云、阳谷霖阳电子科技合伙企业（有限合伙）、阳谷泽阳电子科技 合伙企业（有限合伙）、聊城惠鲁睿高股权投资合伙企业（有限合伙）、聊城昌 润新旧动能转换基金合伙企业（有限合伙）、聊城睿高致远股权投资合伙企业（有 限合伙）、刘保乐（以下合称"交易对方"）购买其合计持有的波米科技有限公司 （以下简称"标的公司"）99.64%股权并募集配套资金（以下 ...

| 证券代码：300121 | 证券简称：阳谷华泰 | 公告编号：2026-003 | | --- | --- | --- | | 债券代码：123211 | 债券简称：阳谷转债 | | 山东阳谷华泰化工股份有限公司 关于召开终止发行股份、支付现金购买资产并募集配套资金事项投资 者说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 3、会议召开方式：网络互动方式 二、参加人员 公司副总经理兼财务总监贺玉广先生、副总经理兼董事会秘书王超先生，交 易对方代表，标的公司代表，独立财务顾问主办人（如遇特殊情况，参会人员可 能进行调整）。 三、投资者参加方式 投 资 者 可 于 2026 年 1 月 9 日 （ 星 期 五 ） 15:00-16:00 通 过 网 址 https://eseb.cn/1us8gWDzqak或使用微信扫描下方小程序码即可进入参与互动交 流。投资者可于2026年1月9日前进行会前提问，公司将通过本次投资者说明会， 在信息披露允许范围内就投资者普遍关注的问题进行回答。 山东阳谷华泰化工股份有限公司（以下简称"公司"）于2025年12月 ...

Core Viewpoint - Yanggu Huatai (300121) has decided to terminate the acquisition of a 99.64% stake in Bomi Technology Co., Ltd. from Hainan Juxin Technology Partnership (Limited Partnership) through the issuance of shares and cash payment, while maintaining a positive outlook on the target company's development prospects [1] Group 1 - The company will negotiate with relevant parties to acquire a portion of the target company's equity in cash instead [1] - The decision reflects the company's commitment to its development strategy of extending into the field of chemical new materials [1] - The specific transaction details will be submitted for the board's review after reaching an agreement with the parties involved [1]